StatOrigin open statistical archive
Industries Indicators Regions Rankings Compare Sources

Regional share of global clinical trial country uses

Share of all global clinical trial country-uses accounted for by a given region.

Unit Percent Industry Healthcare

Cite & reuse Get this data as JSON
Records
6
Regions
3
Period
2019–2023
Sources
1
Verification 6 verified data points Updated 17 Sep 2026 Last verified 17 Sep 2026 Next update Update cycle: irregular

The chart

Across regions

3 regions on one axis, spaced by time. Below it, the latest value of every region, ranked. Forecasts are dashed with hollow markers; the underlying values are one click away under the chart.

Regional share of global clinical trial country uses by region

3 regions, end of 2019 to end of 2023

3 regions · 6 observations · end of 2019 to end of 2023
Regional share of global clinical trial country uses by regionRegional share of global clinical trial country uses by region. 3 regions on one axis: European Union, North America, China. 6 observations from end of 2019 to end of 2023, ranging from 10% to 32%. Latest values: European Union 25% (end of 2023); North America 23% (end of 2023); China 15% (end of 2023). % 0 10 20 30 40 2019 2020 2021 2022 2023 European Union North America China
Regional share of global clinical trial country uses by regionRegional share of global clinical trial country uses by region. 3 regions on one axis: European Union, North America, China. 6 observations from end of 2019 to end of 2023, ranging from 10% to 32%. Latest values: European Union 25% (end of 2023); North America 23% (end of 2023); China 15% (end of 2023). % 0 10 20 30 40 2019 2020 2021 2022 2023 European Union North America China
Regional share of global clinical trial country uses by regionRegional share of global clinical trial country uses by region. 3 regions on one axis: European Union, North America, China. 6 observations from end of 2019 to end of 2023, ranging from 10% to 32%. Latest values: European Union 25% (end of 2023); North America 23% (end of 2023); China 15% (end of 2023). % 0 10 20 30 40 2019 2020 2021 2022 2023 European Union North America China
View the underlying data
Regional share of global clinical trial country uses by region
Region Period Type Value
European Union end of 2023 Actual 25%
European Union end of 2019 Actual 32%
North America end of 2023 Actual 23%
North America end of 2019 Actual 19%
China end of 2023 Actual 15%
China end of 2019 Actual 10%
Source: IQVIA · CC BY 4.0 · statorigin.org
Embed

Free to embed, including commercially. The attribution bar is part of the chart; it is what keeps the data citable. 

<iframe src="https://statorigin.org/embed/healthcare--regional-share-of-global-clinical-trial-country-uses--regions" width="100%" height="380" style="border:1px solid #e2e5e3;border-radius:8px" title="Regional share of global clinical trial country uses by region" loading="lazy"></iframe>
<p><a href="https://statorigin.org/indicators/regional-share-of-global-clinical-trial-country-uses">Regional share of global clinical trial country uses by region</a> — data from StatOrigin, CC BY 4.0</p>
Preview embed

Regional share of global clinical trial country uses by region

Latest value per region, end of 2023

3 entries · ranked
Regional share of global clinical trial country uses by regionRegional share of global clinical trial country uses by region. 3 categories, highest is European Union at 25%. China North America European Union 15% 23% 25%
Regional share of global clinical trial country uses by regionRegional share of global clinical trial country uses by region. 3 categories, highest is European Union at 25%. China North America European Union 15% 23% 25%
Regional share of global clinical trial country uses by regionRegional share of global clinical trial country uses by region. 3 categories, highest is European Union at 25%. China North America European Union 15% 23% 25%
View the underlying data
Regional share of global clinical trial country uses by region
Category Source Type Value
European Union IQVIA Actual 25%
North America IQVIA Actual 23%
China IQVIA Actual 15%
Source: IQVIA · CC BY 4.0 · statorigin.org
Embed

Free to embed, including commercially. The attribution bar is part of the chart; it is what keeps the data citable. 

<iframe src="https://statorigin.org/embed/healthcare--regional-share-of-global-clinical-trial-country-uses--by-region" width="100%" height="380" style="border:1px solid #e2e5e3;border-radius:8px" title="Regional share of global clinical trial country uses by region" loading="lazy"></iframe>
<p><a href="https://statorigin.org/indicators/regional-share-of-global-clinical-trial-country-uses">Regional share of global clinical trial country uses by region</a> — data from StatOrigin, CC BY 4.0</p>
Preview embed

Every record

All records

6 records · 3 regions · 2019–2023

Download CSV JSON series
Regional share of global clinical trial country uses: every record, grouped by region, newest first.
Period Value Source Type
European Union 2 records
end of 2023 25% IQVIA · 31 Dec 2023 actual
end of 2019 32% IQVIA · 31 Dec 2019 actual
North America 2 records
end of 2023 23% IQVIA · 31 Dec 2023 actual
end of 2019 19% IQVIA · 31 Dec 2019 actual
China 2 records
end of 2023 15% IQVIA · 31 Dec 2023 actual
end of 2019 10% IQVIA · 31 Dec 2019 actual

Primary documents

Sources

1 document. Each links to the publisher's own copy.

Document Publisher Published Data points
Rethinking Clinical Trial Country Prioritization IQVIA — 6

Cite & reuse

Cite this page

Data on this page is published under CC BY 4.0. You may reuse it, including commercially, provided you attribute it. To cite one figure, open its record: each carries APA, MLA, Chicago and BibTeX forms that credit the original publisher.

StatOrigin. (2026). Regional share of global clinical trial country uses. Retrieved from https://statorigin.org/indicators/regional-share-of-global-clinical-trial-country-uses

Download CSV Get this data as JSON Compare with… API docs